A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Glaukos Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 173,398 shares of GKOS stock, worth $27.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
173,398
Previous 200,000 13.3%
Holding current value
$27.8 Million
Previous $23.7 Million 4.56%
% of portfolio
0.04%
Previous 0.05%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$113.62 - $135.39 $3.02 Million - $3.6 Million
-26,602 Reduced 13.3%
173,398 $22.6 Million
Q4 2023

Feb 14, 2024

SELL
$59.53 - $85.11 $14.9 Million - $21.3 Million
-250,000 Reduced 55.56%
200,000 $15.9 Million
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $13.8 Million - $15.8 Million
-200,000 Reduced 30.77%
450,000 $33.9 Million
Q2 2023

Aug 14, 2023

BUY
$45.44 - $71.21 $12.8 Million - $20.1 Million
281,900 Added 76.58%
650,000 $46.3 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $7.85 Million - $9.39 Million
179,000 Added 94.66%
368,100 $18.4 Million
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $5.63 Million - $7.96 Million
-137,900 Reduced 42.17%
189,100 $8.26 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $15.3 Million - $19.1 Million
327,000 New
327,000 $17.4 Million
Q4 2020

Feb 16, 2021

SELL
$48.9 - $75.26 $8.56 Million - $13.2 Million
-175,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$37.23 - $50.97 $6.52 Million - $8.92 Million
175,000 New
175,000 $8.67 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.63B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.